BioNexus Gene Lab Corp. has filed an IPO in the amount of $17.25 million.
Security Name: Common Stock
Security Type: Common Stock
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.598 USD | +3.09% | -0.03% | +12.83% |
04-16 | BioNexus Gene Lab Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-29 | BioNexus Gene Lab Corp. Provides Information to Shareholders | CI |
1st Jan change | Capi. | |
---|---|---|
+12.83% | 10.25M | |
+27.47% | 48.16B | |
-0.94% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.22% | 25.59B | |
-22.89% | 18.96B | |
+7.89% | 12.92B | |
+29.29% | 12.03B | |
-2.21% | 11.77B |